You have 9 free searches left this month | for more free features.

HA22

Showing 1 - 25 of 3,001

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Non Hodgkin's Lymphoma, NHL, Aggressive NHL Trial in United States (Veltuzumab and 90Y-Epratuzumab Tetraxetan, 90Y-epratuzumab

Withdrawn
  • Non Hodgkin's Lymphoma
  • +3 more
  • Veltuzumab and 90Y-Epratuzumab Tetraxetan
  • +2 more
  • Newark, Delaware
  • +6 more
Aug 12, 2021

Relapsed/Refractory Hairy Cell Leukemia Trial (Moxetumomab Pasudotox)

Approved for marketing
  • Relapsed/Refractory Hairy Cell Leukemia
  • Moxetumomab Pasudotox
  • (no location specified)
Jun 26, 2020

Non-Hodgkins Lymphoma Trial in Worldwide (Glofitamab, Atezolizumab, Obinutuzumab)

Recruiting
  • Non-Hodgkins Lymphoma
  • Charlotte, North Carolina
  • +21 more
Jan 18, 2023

COVID-19, SARS-CoV-2 Trial in Worldwide (AZD1222, AZD2816)

Active, not recruiting
  • COVID-19
  • SARS-CoV-2
  • AZD1222
  • AZD2816
  • Brasilia, Brazil
  • +34 more
Jun 27, 2022

Osteoarthritis, Knee, Osteoarthritis, Hip Trial in Poland, United Kingdom, United States (Fasinumab, Naproxen, Diclofenac)

Terminated
  • Osteoarthritis, Knee
  • Osteoarthritis, Hip
  • Phoenix, Arizona
  • +14 more
Aug 24, 2021

Osteoarthritis, Knee Trial in Northwood (APS)

Completed
  • Osteoarthritis, Knee
  • APS
  • Northwood, United Kingdom
    BMI Bishops Wood Hospital
Jun 11, 2020

Postmenopausal Osteoporosis Trial in Worldwide (Romozosumab, Teriparatide)

Completed
  • Postmenopausal Osteoporosis
  • Gainesville, Georgia
  • +49 more
Nov 4, 2022

Squamous Cell Oesophageal Carcinoma Receiving Nivolumab as Part

Completed
  • Esophageal Squamous Cell Carcinoma
  • Nivolumab
  • Truro, Cornwall, United Kingdom
  • +35 more
May 18, 2022

Hyperkalemia Trial in Worldwide (Patiromer, Placebos)

Completed
  • Hyperkalemia
  • Alexander City, Alabama
  • +414 more
Jan 11, 2022

Osteoarthritis Trial in United Kingdom (Total Ankle Replacement, Arthrodesis)

Active, not recruiting
  • Osteoarthritis
  • Total Ankle Replacement
  • Arthrodesis
  • Truro, Cornwall, United Kingdom
  • +16 more
Mar 12, 2021

Intracranial Hemorrhages, Intracranial Hemorrhage, Hypertensive, Subarachnoid Hemorrhage Trial in United Kingdom (Apixaban,

Completed
  • Intracranial Hemorrhages
  • +8 more
  • Edinburgh, Midlothian, United Kingdom
  • +66 more
Mar 31, 2022

Osteoarthritis, Knee, Osteoarthritis, Hip Trial in Poland, United Kingdom, United States (Fasinumab, Placebo)

Completed
  • Osteoarthritis, Knee
  • Osteoarthritis, Hip
  • Glendale, Arizona
  • +46 more
Dec 2, 2021

Moderate-to-severe Atopic Dermatitis Trial in China (CBP-201, Placebo)

Recruiting
  • Moderate-to-severe Atopic Dermatitis
  • Hefei, Anhui, China
  • +55 more
Sep 22, 2021

Painful Osteoarthritis of the Knee Trial in Worldwide (MEDI7352, Placebo)

Recruiting
  • Painful Osteoarthritis of the Knee
  • MEDI7352
  • Placebo
  • Montclair, California
  • +92 more
Aug 24, 2022

Acute Myocardial Infarction, Heart Failure Trial in Sweden, United Kingdom (Dapagliflozin, Placebo)

Recruiting
  • Acute Myocardial Infarction
  • Heart Failure
  • Alingsås, Sweden
  • +112 more
Aug 18, 2022

Post-Menopausal Osteoporosis Trial in Poland, United Kingdom, United States (romosozumab HCP administration with PFS,

Completed
  • Post-Menopausal Osteoporosis
  • romosozumab HCP administration with PFS
  • romosozumab self-administration with AI/Pen
  • Birmingham, Alabama
  • +45 more
Nov 5, 2020

KRAS p, G12c Mutated /Advanced Metastatic NSCLC Trial in Worldwide (AMG 510, Docetaxel)

Active, not recruiting
  • KRAS p, G12c Mutated /Advanced Metastatic NSCLC
  • Anaheim, California
  • +273 more
Nov 10, 2022

Optical Coherence Tomography, Optical Coherence Tomography Angiography Trial in Amiens (Optical coherence tomography

Recruiting
  • Optical Coherence Tomography
  • Optical Coherence Tomography Angiography
  • Optical coherence tomography angiography
  • ophthalmological exam
  • Amiens, France
    Amiens University Hospital
Sep 19, 2023

Crohn Disease, Remission Trial in Worldwide (5-ASA Withdrawal)

Recruiting
  • Crohn Disease
  • Remission
  • 5-ASA Withdrawal
  • Calgary, Alberta, Canada
  • +45 more
Apr 1, 2021

Peri-implant Mucositis, Mucositis Oral Trial in Naples (Application NaOCl gel + HA gel, Non-surgical mechanical debridement)

Recruiting
  • Peri-implant Mucositis
  • Mucositis Oral
  • Application NaOCl gel + HA gel
  • Non-surgical mechanical debridement
  • Naples, Italy
    University of Naples Federico II
Jul 3, 2023

Osteoarthritis of the Knee or Hip Trial in Worldwide (Fasinumab, Placebo)

Completed
  • Osteoarthritis of the Knee or Hip
  • Birmingham, Alabama
  • +149 more
Nov 30, 2021

Periodontitis Trial in Sanya (HA35(L20200708MP07707, Ministry of Health, Mongolia) was freshly manufactured by mixing

Completed
  • Periodontitis
  • HA35(L20200708MP07707, Ministry of Health, Mongolia) was freshly manufactured by mixing hyaluronidase PH20 injectable solution (H31022111) and high-molecular-weight HA injectable solution (H20174089)
  • Sanya, Hainan, China
    Sanya Central Hospital
Mar 13, 2023

Influenza Trial in South Jordan (mRNA-1018 for H5N8, mRNA-1018 for H7N9, mRNA-1018 for H5 Only)

Recruiting
  • Influenza
  • mRNA-1018 for H5N8
  • +4 more
  • South Jordan, Utah
    J. Lewis Research, Inc/Jordan River Family Medicine
Jul 25, 2023

Influenza, Human Trial in Georgia, Turkey (aQIV, QIV)

Not yet recruiting
  • Influenza, Human
  • aQIV
  • QIV
  • Batumi, Georgia
  • +16 more
Oct 11, 2023

Stroke, Acute, Atrial Fibrillation Trial in United Kingdom (Direct oral anticoagulant (DOAC))

Recruiting
  • Stroke, Acute
  • Atrial Fibrillation
  • Direct oral anticoagulant (DOAC)
  • Aberystwyth, United Kingdom
  • +43 more
Nov 6, 2020